<div id="readability-page-1"><p>Weybosset Research &amp; Management LLC cut its holdings in  MaxLinear, Inc (NASDAQ:MXL - Free Report) by 26.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 205,893 shares of the semiconductor company's stock after selling 72,801 shares during the period. MaxLinear comprises about  1.1% of Weybosset Research &amp; Management LLC's holdings, making the stock its 23rd largest position. Weybosset Research &amp; Management LLC owned 0.24% of MaxLinear worth $3,311,000 at the end of the most recent quarter.</p><ul><li>Silicon Motion: The Market's Best Merger Arbitrage Opportunity</li></ul><p>Other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC purchased a new position in shares of  MaxLinear during the second quarter worth approximately $44,000.  PNC Financial Services Group Inc. raised its stake in  MaxLinear by 104.4% during the 2nd quarter. PNC Financial Services Group Inc. now owns 3,579 shares of the semiconductor company's stock valued at $51,000 after acquiring an additional 1,828 shares during the last quarter.  Raymond James Financial Inc. purchased a new stake in  MaxLinear during the 2nd quarter valued at approximately $51,000.  Strs Ohio purchased a new position in shares of  MaxLinear in the 1st quarter valued at approximately $63,000.  Finally, GAMMA Investing LLC lifted its holdings in shares of  MaxLinear by 36.6% during the second quarter. GAMMA Investing LLC now owns 5,143 shares of the semiconductor company's stock worth $73,000 after purchasing an additional 1,378 shares during the period. Hedge funds and other institutional investors own  90.79% of the company's stock. </p><h2>MaxLinear Stock Down 0.8%</h2><p>NASDAQ MXL opened at $17.58 on Tuesday. The company has a market capitalization of $1.54 billion, a P/E ratio of -8.41 and a beta of 1.82. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.55 and a quick ratio of 1.08. The company's 50 day simple moving average is $16.20 and its 200 day simple moving average is $15.74. MaxLinear, Inc has a 12 month low of $8.35 and a 12 month high of $25.73. </p><ul><li>2 M&amp;A Deals Trading at Wide Spreads: A Game of Regulatory Risk</li></ul><p>MaxLinear (NASDAQ:MXL - Get Free Report) last posted its quarterly earnings data on Thursday, October 23rd. The semiconductor company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.02. MaxLinear had a negative return on equity of 12.74% and a negative net margin of 42.43%.The firm had revenue of $126.46 million for the quarter, compared to the consensus estimate of $124.66 million. During the same quarter in the previous year, the company earned ($0.36) EPS. The business's revenue for the quarter was up 56.0% compared to the same quarter last year.  Equities research analysts expect that  MaxLinear, Inc will post -0.37 earnings per share for the current fiscal year. </p><p>MaxLinear declared that its board has authorized a share buyback plan on Monday, November 24th that authorizes the company to repurchase $75.00 million in  outstanding  shares. This repurchase authorization authorizes the semiconductor company to reacquire up to 5.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued. </p><h2>Insider Transactions at MaxLinear</h2><ul><li>MaxLinear Stock is a Worthy Chip Play</li></ul><p>In related news, Director Daniel A. Artusi sold 20,747 shares of MaxLinear stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $15.39, for a total value of $319,296.33. Following the transaction, the director owned 12,141 shares in the company, valued at $186,849.99. This trade represents a 63.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 7.80% of the stock is owned by insiders. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research analysts recently weighed in on the company. Zacks Research lowered MaxLinear from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Monday, September 22nd. Stifel Nicolaus  set a $23.00 price target on MaxLinear in a research report on Friday, October 24th. Weiss Ratings  reaffirmed a &#34;sell (d-)&#34; rating on shares of MaxLinear in a research report on Wednesday, October 8th. Benchmark  reaffirmed a &#34;buy&#34; rating and set a $25.00 target price on shares of MaxLinear in a research report on Friday, October 24th. Finally, Wall Street Zen upgraded shares of MaxLinear from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, September 20th. Three investment analysts have rated the stock with a Buy rating, six have assigned  a Hold rating and one  has issued  a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Hold&#34; and a consensus price target of $19.94.</p><p><b>Read Our Latest Research Report on MXL</b></p><h2>MaxLinear Company Profile</h2> (Free Report)<p>MaxLinear, Inc is a provider of radio-frequency (RF), analog, and mixed-signal integrated circuits for broadband communications, data center connectivity, and video infrastructure applications. The company's product portfolio includes high-performance RF front-end modules, broadband power amplifiers, optical and Ethernet transceivers, and network processors designed to support demanding signal processing requirements.  </p><p>MaxLinear's semiconductor solutions are used by cable and satellite television operators, fiber-to-the-home service providers, network equipment manufacturers, and data center operators.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than MaxLinear</li><li>Bombshell Exposé on China Strikes</li><li>ALERT: Drop these 5 stocks before January 2026!</li><li>Wall Street Stockpicker Names #1 Stock of 2026</li><li>Chilling warning from legendary investor</li><li>Trump’s new AI budget just passed — one stock could soar</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TVhM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TVhM"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in MaxLinear Right Now?</h2><p>Before you consider MaxLinear, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.</p><p>While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Weybosset Research & Management LLC reduced its holdings in MaxLinear, Inc (NASDAQ:MXL) by 26.1% in Q3, now owning 205,893 shares. The firm’s stake in MaxLinear is valued at $3.31 million, making it the 23rd largest position. Other institutional investors have also adjusted their stakes. MaxLinear's stock opened at $17.58, with a market cap of $1.54 billion. The company reported $0.14 EPS for the last quarter, exceeding estimates, and announced a $75 million share buyback plan. Analyst ratings vary, with some upgrades and downgrades noted recently.</p>

Weybosset Research & Management LLC Cuts Holdings in MaxLinear, Inc $MXL